Table 8 Results of survival analysis in the validation cohort: grouping by predictive factors
Median DFS (months) | 95% CI | p value | |
|---|---|---|---|
T1WI_NGTDM_Strength | 0.073 | ||
Low-T1WI_NGTDM_Strength (n = 8) | 5.4 | 2.6–8.2 | |
High-T1WI_NGTDM_Strength (n = 7) | 28.0 | 13.7–42.3 | |
Tumour location | 0.050 | ||
Pancreatic head (n = 8) | 7.0 | 4.0–10.0 | |
Pancreatic neck, body, and tail (n = 7) | 28.0 | 0.0–62.9 | |
Total (n = 15) | 11.0 | 4.0–18.0 |